Candel Therapeutics (CADL) had the highest return between October 1, 2023 and September 30, 2024 by a small-cap US stock, returning 617.4%.
| ASSET | DATE | % RETURN |
|---|---|---|
Candel Therapeutics (CADL) | 10/1/2023 - 9/30/2024 | 617.39% |
Power Solutions International, Inc Common Stock (PSIX) | 10/1/2023 - 9/30/2024 | 526.52% |
Jade Biosciences (JBIO) | 10/1/2023 - 9/30/2024 | 452.78% |
ESGL (OIO) | 10/1/2023 - 9/30/2024 | 361.72% |
Janux Therapeutics (JANX) | 10/1/2023 - 9/30/2024 | 355.67% |
Personalis (PSNL) | 10/1/2023 - 9/30/2024 | 340.98% |
Capricor Therapeutics (CAPR) | 10/1/2023 - 9/30/2024 | 335.82% |
Root (ROOT) | 10/1/2023 - 9/30/2024 | 302.34% |
Nano Nuclear Energy Inc Common Stock (NNE) | 10/1/2023 - 9/30/2024 | 300.28% |
ARS Pharmaceuticals (SPRY) | 10/1/2023 - 9/30/2024 | 282.59% |
Real Brokerage (REAX) | 10/1/2023 - 9/30/2024 | 277.55% |
Lendingtree (TREE) | 10/1/2023 - 9/30/2024 | 275.11% |
Rezolute (RZLT) | 10/1/2023 - 9/30/2024 | 273.08% |
Bioventus (BVS) | 10/1/2023 - 9/30/2024 | 263.22% |
Willis Lease Finance (WLFC) | 10/1/2023 - 9/30/2024 | 262.83% |
Corvus Pharmaceuticals (CRVS) | 10/1/2023 - 9/30/2024 | 249.67% |
Grupo Supervielle (SUPV) | 10/1/2023 - 9/30/2024 | 234.24% |
Mesoblast (MESO) | 10/1/2023 - 9/30/2024 | 232.11% |
Aquestive Therapeutics (AQST) | 10/1/2023 - 9/30/2024 | 225.49% |
Aspen Aerogels (ASPN) | 10/1/2023 - 9/30/2024 | 223.1% |
Idaho Strategic Resources (IDR) | 10/1/2023 - 9/30/2024 | 221.4% |
Pennant (PNTG) | 10/1/2023 - 9/30/2024 | 221.04% |
Harrow Health (HROW) | 10/1/2023 - 9/30/2024 | 215.51% |
American Superconductor (AMSC) | 10/1/2023 - 9/30/2024 | 215.09% |
Stoke Therapeutics (STOK) | 10/1/2023 - 9/30/2024 | 212.72% |
Small-cap stocks are treated as having a market cap between $300M and $2B.